MEMPHIS PHARMACEUTICALS & CHEMICAL INDUSTRIES

Memphis Pharmaceuticals & Chemical Industries

MPCI

EGS38351C010

Pharmaceuticals

End-of-day quote Egyptian Exchange Other stock markets 18:00:00 2024-05-22 EDT			5-day change	1st Jan Change
83.73 ^EGP	0.00%		+11.51%	+33.52%

02-14	Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2023	CI
2023	Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2023	CI

Memphis Pharmaceuticals Reports Earnings Results for the Nine Months Ended March 31, 2016

May 14, 2016 at 06:31 am

Memphis Pharmaceuticals reported earnings results for the nine months ended March 31, 2016. For the period, the company reported net profit of EGP 405,660 compared to net loss of EGP 11,645,986 a year ago.

Latest news about Memphis Pharmaceuticals & Chemical Industries

Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2023	02-14	CI
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2023	11-14	CI
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2023	23-05-13	CI
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-09	CI
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-20	CI
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2022	22-05-16	CI
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-15	CI
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2021	21-11-13	CI
Memphis Pharmaceutical and Chemical Industries Announces Board Appointments	21-06-07	CI
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2021	21-05-30	CI
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2020	21-02-11	CI
Memphis Pharmaceuticals Reports Earnings Results for the First Quarter Ended September 30, 2019	19-11-12	CI
Memphis Pharmaceuticals & Chemical Industries Announces Audited Earnings Results for the Year Ended June 30, 2019	19-09-08	CI
Memphis Pharmaceuticals & Chemical Industries Announces Earnings Results for the Nine Months Ended March 31, 2019	19-05-14	CI
Memphis Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2018	19-02-13	CI
Memphis Pharmaceuticals and Chemical Industries Company Announces Audited Earnings Results for the Year Ended June 30, 2018	18-08-29	CI
Memphis Pharmaceuticals Announces Earnings Results for the Nine Months Ended March 31, 2018	18-05-12	CI
Memphis Pharmaceuticals and Chemical Industries Company Announces Earnings Results for the Six Months Ended Dec. 31, 2017	18-02-13	CI
Memphis Pharmaceuticals and Chemical Industries Company Announces Earnings Results for the Three Months Period Ended September 30, 2017	17-11-12	CI
Memphis Pharmaceuticals Reports Audited Earnings Results for the Year Ended June 30, 2017	17-09-09	CI
Memphis Pharmaceuticals Announces Executive Changes	17-07-09	CI
Memphis Pharmaceuticals Announces Audited Earnings Results for the Nine Months Ended March 31, 2017	17-05-14	CI
Memphis Pharmaceuticals Announces Earnings Results for the Half Year Ended December 31, 2016	17-02-13	CI
Memphis Pharmaceuticals Reports Earnings Results for the Nine Months Ended March 31, 2016	16-05-14	CI
Memphis Pharmaceuticals and Chemical Industries Company Announces Reviewed Earnings Results for the First Six Months Ended December 31, 2015	16-02-16	CI

Chart Memphis Pharmaceuticals & Chemical Industries

Duration

Period

Chart Memphis Pharmaceuticals & Chemical Industries

More charts

Company Profile

Memphis Pharmaceutical and Chemical Industries S.A.E. specializes in researching, manufacturing and marketing pharmaceutical products. The group's products include effervescent, syrups, ointments, injections, tablets and suppositories.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
MEMPHIS PHARMACEUTICALS & CHEMICAL INDUSTRIES	+33.52%	10.07M
ELI LILLY AND COMPANY	+38.69%	723B
NOVO NORDISK A/S	+34.28%	595B
JOHNSON & JOHNSON	-4.49%	369B
MERCK & CO., INC.	+20.24%	332B
ABBVIE INC.	+2.12%	282B
ASTRAZENECA PLC	+17.02%	244B
NOVARTIS AG	+9.31%	208B
ROCHE HOLDING AG	-5.07%	205B
PFIZER, INC.	-0.35%	168B